Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Boucher

Showing results (141-150 of 180) with videos related to

Pageof 18
Sort By:
AIDS Research and Human Retroviruses|September 14, 2017
A Summary of the Second Annual HIV Microbiome WorkshopBrett Williams, Mimi Ghosh, Charles A B Boucher, et al.
Journal of the International AIDS Society|December 11, 2014
Increasing the use of second-line therapy is a cost-effective approach to prevent the spread of drug-resistant HIV: a mathematical modelling studyBrooke E Nichols, Kim C E Sigaloff, Cissy Kityo, et al.
Antiviral Therapy|May 11, 2011
Baseline CD4(+) T-cell counts and weighted background susceptibility scores strongly predict response to maraviroc regimens in treatment-experienced patientsJonathan M Schapiro, Charles A B Boucher, Daniel R Kuritzkes, et al.
Hepatology (Baltimore, Md.)|August 5, 2010
Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levelsVincent Rijckborst, Bettina E Hansen, Yilmaz Cakaloglu, et al.
Journal of Virus Eradication|June 18, 2021
Launching a multidisciplinary European collaboration towards a cure for HIV: The EU2Cure ConsortiumC Rokx, H A B Prins, L Vandekerckhove, et al.
Plos Pathogens|October 3, 2012
H1N1 2009 pandemic influenza virus: resistance of the I223R neuraminidase mutant explained by kinetic and structural analysisErhard van der Vries, Patrick J Collins, Sebastien G Vachieri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2020
Transmission of NS5A-Inhibitor Resistance-Associated Substitutions Among Men Who Have Sex With Men Recently Infected with Hepatitis C Virus Genotype 1aStephanie Popping, Rosanne Verwijs, Lize Cuypers, et al.
Viruses|September 23, 2022
Persistent Transmission of HCV among Men Who Have Sex with Men despite Widespread Screening and Treatment with Direct-Acting AntiviralsStephanie Popping, Lize Cuypers, Mark A A Claassen, et al.
Nature Communications|May 1, 2021
Selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoirShringar Rao, Cynthia Lungu, Raquel Crespo, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 5, 2013
Leflunomide as part of the treatment for multidrug-resistant cytomegalovirus disease after lung transplantation: case report and review of the literatureN J Verkaik, R A S Hoek, H van Bergeijk, et al.
Pageof 18

Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
AIDS Research and Human Retroviruses|September 14, 2017
A Summary of the Second Annual HIV Microbiome WorkshopBrett Williams, Mimi Ghosh, Charles A B Boucher, et al.
Journal of the International AIDS Society|December 11, 2014
Increasing the use of second-line therapy is a cost-effective approach to prevent the spread of drug-resistant HIV: a mathematical modelling studyBrooke E Nichols, Kim C E Sigaloff, Cissy Kityo, et al.
Antiviral Therapy|May 11, 2011
Baseline CD4(+) T-cell counts and weighted background susceptibility scores strongly predict response to maraviroc regimens in treatment-experienced patientsJonathan M Schapiro, Charles A B Boucher, Daniel R Kuritzkes, et al.
Hepatology (Baltimore, Md.)|August 5, 2010
Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levelsVincent Rijckborst, Bettina E Hansen, Yilmaz Cakaloglu, et al.
Journal of Virus Eradication|June 18, 2021
Launching a multidisciplinary European collaboration towards a cure for HIV: The EU2Cure ConsortiumC Rokx, H A B Prins, L Vandekerckhove, et al.
Plos Pathogens|October 3, 2012
H1N1 2009 pandemic influenza virus: resistance of the I223R neuraminidase mutant explained by kinetic and structural analysisErhard van der Vries, Patrick J Collins, Sebastien G Vachieri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2020
Transmission of NS5A-Inhibitor Resistance-Associated Substitutions Among Men Who Have Sex With Men Recently Infected with Hepatitis C Virus Genotype 1aStephanie Popping, Rosanne Verwijs, Lize Cuypers, et al.
Viruses|September 23, 2022
Persistent Transmission of HCV among Men Who Have Sex with Men despite Widespread Screening and Treatment with Direct-Acting AntiviralsStephanie Popping, Lize Cuypers, Mark A A Claassen, et al.
Nature Communications|May 1, 2021
Selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoirShringar Rao, Cynthia Lungu, Raquel Crespo, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 5, 2013
Leflunomide as part of the treatment for multidrug-resistant cytomegalovirus disease after lung transplantation: case report and review of the literatureN J Verkaik, R A S Hoek, H van Bergeijk, et al.
Pageof 18